Mass General Brigham at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Mass General Brigham brings 2 presentations to SITC 2026 in Phoenix. Its program centres on melanoma biology and on joint side effects of checkpoint inhibitors. One study shows galectin-9 made by cancer cells, downstream of interferon signalling, helping melanoma grow, and another describes the features, management and outcomes of inflammatory arthritis after checkpoint treatment.
| Organization | SITC 2026 Attendance |
|---|---|
Mass General Brigham Boston, MA | |
Integrated academic health system providing patient care, research and medical education. | Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from Mass General Brigham
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction